United States Biotechnology & Medical Research

Novartis Vaccines and Diagnostics Inc (CHIR)

Track

Stock chart
Ticker: CHIR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RAPPUOLI RINO
V.P., Chief Scientific Officer
7 sales — total 4,552,757 USD
Sale 18 Apr 2006
Value US$1,038,480.51 | Price 342.25 | Shares 89,137
Sale 18 Apr 2006
Value US$4,790,695.21 | Price 15.07 | Shares 37,330
Sale 18 Apr 2006
Value US$719,250.00 | Price 47.95 | Shares 15,000
Sale 18 Apr 2006
Value US$479,500.00 | Price 47.95 | Shares 10,000
Sale 18 Apr 2006
Value US$959,000.00 | Price 47.95 | Shares 20,000
Sale 18 Apr 2006
Value US$959,000.00 | Price 47.95 | Shares 20,000
Sale 18 Apr 2006
Value US$134,835.40 | Price 47.95 | Shares 2,812
Planned sale 29 Apr 2004
Value US$4,556,082.73 | Price 424.90 | Shares 87,345
Planned sale 28 Apr 2004
Value US$433,170.00 | Price 48.13 | Shares 9,000
Planned sale 27 Apr 2004
Value US$432,000.00 | Price 48.00 | Shares 9,000
Planned sale 12 Apr 2004
Value US$45,500.00 | Price 45.50 | Shares 1,000
Planned sale 12 Apr 2004
Value US$5,917.60 | Price 45.52 | Shares 130
Planned sale 12 Apr 2004
Value US$45,540.00 | Price 45.54 | Shares 1,000
Planned sale 12 Apr 2004
Value US$45,600.00 | Price 45.60 | Shares 1,000
Planned sale 8 Apr 2004
Value US$184,400.00 | Price 46.10 | Shares 4,000
Planned sale 8 Apr 2004
Value US$92,360.00 | Price 46.18 | Shares 2,000
Planned sale 8 Apr 2004
Value US$92,460.00 | Price 46.23 | Shares 2,000
Planned sale 8 Apr 2004
Value US$46,330.00 | Price 46.33 | Shares 1,000
Planned sale 7 Apr 2004
Value US$4,564.00 | Price 45.64 | Shares 100
Planned sale 7 Apr 2004
Value US$31,962.00 | Price 45.66 | Shares 700
Planned sale 7 Apr 2004
Value US$68,520.00 | Price 45.68 | Shares 1,500
Planned sale 7 Apr 2004
Value US$100,974.90 | Price 45.69 | Shares 2,210
Planned sale 7 Apr 2004
Value US$201,080.00 | Price 45.70 | Shares 4,400
Planned sale 7 Apr 2004
Value US$4,116.15 | Price 45.74 | Shares 90
Planned sale 6 Apr 2004
Value US$186,132.53 | Price 45.97 | Shares 4,049
Planned sale 6 Apr 2004
Value US$4,598.00 | Price 45.98 | Shares 100
Planned sale 6 Apr 2004
Value US$46,000.00 | Price 46.00 | Shares 1,000
Planned sale 6 Apr 2004
Value US$4,601.00 | Price 46.01 | Shares 100
Planned sale 6 Apr 2004
Value US$9,204.00 | Price 46.02 | Shares 200
Planned sale 6 Apr 2004
Value US$163,594.57 | Price 46.07 | Shares 3,551
Planned sale 5 Apr 2004
Value US$31,899.00 | Price 45.57 | Shares 700
Planned sale 5 Apr 2004
Value US$136,800.00 | Price 45.60 | Shares 3,000
Planned sale 5 Apr 2004
Value US$50,204.00 | Price 45.64 | Shares 1,100
Planned sale 5 Apr 2004
Value US$9,130.00 | Price 45.65 | Shares 200
Planned sale 5 Apr 2004
Value US$59,371.00 | Price 45.67 | Shares 1,300
Planned sale 5 Apr 2004
Value US$50,259.00 | Price 45.69 | Shares 1,100
Planned sale 5 Apr 2004
Value US$36,560.00 | Price 45.70 | Shares 800
Planned sale 5 Apr 2004
Value US$32,018.00 | Price 45.74 | Shares 700
Planned sale 5 Apr 2004
Value US$4,575.00 | Price 45.75 | Shares 100
Planned sale 2 Apr 2004
Value US$405,000.00 | Price 45.00 | Shares 9,000
Planned sale 29 Mar 2004
Value US$407,340.00 | Price 45.26 | Shares 9,000
Planned sale 26 Mar 2004
Value US$112,500.00 | Price 45.00 | Shares 2,500
Planned sale 23 Mar 2004
Value US$405,900.00 | Price 45.10 | Shares 9,000
Planned sale 22 Mar 2004
Value US$405,900.00 | Price 45.10 | Shares 9,000
Planned sale 19 Mar 2004
Value US$416,700.00 | Price 46.30 | Shares 9,000
Planned sale 18 Mar 2004
Value US$419,850.00 | Price 46.65 | Shares 9,000
Planned sale 17 Mar 2004
Value US$205,127.80 | Price 46.94 | Shares 4,370
Planned sale 17 Mar 2004
Value US$217,332.20 | Price 46.94 | Shares 4,630
Planned sale 16 Mar 2004
Value US$421,740.00 | Price 46.86 | Shares 9,000
Planned sale 15 Mar 2004
Value US$428,940.00 | Price 47.66 | Shares 9,000
Planned sale 12 Mar 2004
Value US$428,400.00 | Price 47.60 | Shares 9,000
Planned sale 11 Mar 2004
Value US$429,480.00 | Price 47.72 | Shares 9,000
Planned sale 10 Mar 2004
Value US$434,340.00 | Price 48.26 | Shares 9,000
Planned sale 9 Mar 2004
Value US$434,430.00 | Price 48.27 | Shares 9,000
Planned sale 8 Mar 2004
Value US$444,330.00 | Price 49.37 | Shares 9,000
Planned sale 5 Mar 2004
Value US$438,930.00 | Price 48.77 | Shares 9,000
Planned sale 4 Mar 2004
Value US$291,180.00 | Price 48.53 | Shares 6,000
Planned sale 4 Mar 2004
Value US$145,590.00 | Price 48.53 | Shares 3,000
Planned sale 3 Mar 2004
Value US$439,920.00 | Price 48.88 | Shares 9,000
Planned sale 2 Mar 2004
Value US$73,800.00 | Price 49.20 | Shares 1,500
Planned sale 2 Mar 2004
Value US$147,660.00 | Price 49.22 | Shares 3,000
Planned sale 2 Mar 2004
Value US$74,100.00 | Price 49.40 | Shares 1,500
Planned sale 2 Mar 2004
Value US$74,250.00 | Price 49.50 | Shares 1,500
Planned sale 2 Mar 2004
Value US$74,415.00 | Price 49.61 | Shares 1,500
Planned sale 1 Mar 2004
Value US$148,140.00 | Price 49.38 | Shares 3,000
Planned sale 1 Mar 2004
Value US$148,020.00 | Price 49.34 | Shares 3,000
Planned sale 1 Mar 2004
Value US$147,300.00 | Price 49.10 | Shares 3,000
Planned sale 27 Feb 2004
Value US$443,790.00 | Price 49.31 | Shares 9,000
Planned sale 26 Feb 2004
Value US$442,620.00 | Price 49.18 | Shares 9,000
Planned sale 25 Feb 2004
Value US$442,800.00 | Price 49.20 | Shares 9,000
Planned sale 24 Feb 2004
Value US$441,360.00 | Price 49.04 | Shares 9,000
Planned sale 23 Feb 2004
Value US$444,150.00 | Price 49.35 | Shares 9,000
Planned sale 20 Feb 2004
Value US$452,700.00 | Price 50.30 | Shares 9,000
Planned sale 19 Feb 2004
Value US$459,270.00 | Price 51.03 | Shares 9,000
Planned sale 18 Feb 2004
Value US$452,340.00 | Price 50.26 | Shares 9,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
89,137 +20.5%
342.25
US$1,038,481 		89,137 +20.5% 342.25 US$1,038,481
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
37,330 -32.5%
15.07
US$4,790,695 		37,330 -32.5% 15.07 US$4,790,695
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
64,424 -29.7%
224.25
US$4,191,905 		64,424 -29.7% 224.25 US$4,191,905
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
10,000 -41.4%
47.95
US$479,500 		10,000 -41.4% 47.95 US$479,500
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
20,000 -58.6%
47.95
US$959,000 		20,000 -58.6% 47.95 US$959,000
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
20,000 -58.6%
47.95
US$959,000 		20,000 -58.6% 47.95 US$959,000
2006-04-19 2006-04-18 S Sale RAPPUOLI RINO

V.P., Chief Scientific Officer

Officer
2,812 -16.6%
47.95
US$134,835 		2,812 -16.6% 47.95 US$134,835
2004-04-29 2004-04-29 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.00
US$432,000 		9,000 -28.9% 48.00 US$432,000
2004-04-29 2004-04-28 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.13
US$433,170 		9,000 -28.9% 48.13 US$433,170
2004-04-28 2004-04-27 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.00
US$432,000 		9,000 -28.9% 48.00 US$432,000
2004-04-12 2004-04-12 PlS Planned sale LANCE SEAN P Non-Executive Director
1,000 -4.3%
45.50
US$45,500 		1,000 -4.3% 45.50 US$45,500
2004-04-12 2004-04-12 PlS Planned sale LANCE SEAN P Non-Executive Director
130 -0.6%
45.52
US$5,918 		130 -0.6% 45.52 US$5,918
2004-04-12 2004-04-12 PlS Planned sale LANCE SEAN P Non-Executive Director
1,000 -4.3%
45.54
US$45,540 		1,000 -4.3% 45.54 US$45,540
2004-04-12 2004-04-12 PlS Planned sale LANCE SEAN P Non-Executive Director
1,000 -4.3%
45.60
US$45,600 		1,000 -4.3% 45.60 US$45,600
2004-04-08 2004-04-08 PlS Planned sale LANCE SEAN P Non-Executive Director
4,000 -15.3%
46.10
US$184,400 		4,000 -15.3% 46.10 US$184,400
2004-04-08 2004-04-08 PlS Planned sale LANCE SEAN P Non-Executive Director
2,000 -8.3%
46.18
US$92,360 		2,000 -8.3% 46.18 US$92,360
2004-04-08 2004-04-08 PlS Planned sale LANCE SEAN P Non-Executive Director
2,000 -8.3%
46.23
US$92,460 		2,000 -8.3% 46.23 US$92,460
2004-04-08 2004-04-08 PlS Planned sale LANCE SEAN P Non-Executive Director
1,000 -4.3%
46.33
US$46,330 		1,000 -4.3% 46.33 US$46,330
2004-04-07 2004-04-07 PlS Planned sale LANCE SEAN P Non-Executive Director
100 -0.4%
45.64
US$4,564 		100 -0.4% 45.64 US$4,564
2004-04-07 2004-04-07 PlS Planned sale LANCE SEAN P Non-Executive Director
700 -3.1%
45.66
US$31,962 		700 -3.1% 45.66 US$31,962
2004-04-07 2004-04-07 PlS Planned sale LANCE SEAN P Non-Executive Director
1,500 -6.3%
45.68
US$68,520 		1,500 -6.3% 45.68 US$68,520
2004-04-07 2004-04-07 PlS Planned sale LANCE SEAN P Non-Executive Director
2,210 -9.1%
45.69
US$100,975 		2,210 -9.1% 45.69 US$100,975
2004-04-07 2004-04-07 PlS Planned sale LANCE SEAN P Non-Executive Director
4,400 -16.6%
45.70
US$201,080 		4,400 -16.6% 45.70 US$201,080
2004-04-07 2004-04-07 PlS Planned sale LANCE SEAN P Non-Executive Director
90 -0.4%
45.74
US$4,116 		90 -0.4% 45.74 US$4,116
2004-04-06 2004-04-06 PlS Planned sale LANCE SEAN P Non-Executive Director
4,049 -15.5%
45.97
US$186,133 		4,049 -15.5% 45.97 US$186,133
2004-04-06 2004-04-06 PlS Planned sale LANCE SEAN P Non-Executive Director
100 -0.4%
45.98
US$4,598 		100 -0.4% 45.98 US$4,598
2004-04-06 2004-04-06 PlS Planned sale LANCE SEAN P Non-Executive Director
1,000 -4.3%
46.00
US$46,000 		1,000 -4.3% 46.00 US$46,000
2004-04-06 2004-04-06 PlS Planned sale LANCE SEAN P Non-Executive Director
100 -0.4%
46.01
US$4,601 		100 -0.4% 46.01 US$4,601
2004-04-06 2004-04-06 PlS Planned sale LANCE SEAN P Non-Executive Director
200 -0.9%
46.02
US$9,204 		200 -0.9% 46.02 US$9,204
2004-04-06 2004-04-06 PlS Planned sale LANCE SEAN P Non-Executive Director
3,551 -13.8%
46.07
US$163,595 		3,551 -13.8% 46.07 US$163,595
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
700 -3.1%
45.57
US$31,899 		700 -3.1% 45.57 US$31,899
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
3,000 -11.9%
45.60
US$136,800 		3,000 -11.9% 45.60 US$136,800
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
1,100 -4.7%
45.64
US$50,204 		1,100 -4.7% 45.64 US$50,204
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
200 -0.9%
45.65
US$9,130 		200 -0.9% 45.65 US$9,130
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
1,300 -5.5%
45.67
US$59,371 		1,300 -5.5% 45.67 US$59,371
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
1,100 -4.7%
45.69
US$50,259 		1,100 -4.7% 45.69 US$50,259
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
800 -3.5%
45.70
US$36,560 		800 -3.5% 45.70 US$36,560
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
700 -3.1%
45.74
US$32,018 		700 -3.1% 45.74 US$32,018
2004-04-05 2004-04-05 PlS Planned sale LANCE SEAN P Non-Executive Director
100 -0.4%
45.75
US$4,575 		100 -0.4% 45.75 US$4,575
2004-04-02 2004-04-02 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
45.00
US$405,000 		9,000 -28.9% 45.00 US$405,000
2004-03-29 2004-03-29 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
45.26
US$407,340 		9,000 -28.9% 45.26 US$407,340
2004-03-26 2004-03-26 PlS Planned sale LANCE SEAN P Non-Executive Director
2,500 -10.1%
45.00
US$112,500 		2,500 -10.1% 45.00 US$112,500
2004-03-23 2004-03-23 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
45.10
US$405,900 		9,000 -28.9% 45.10 US$405,900
2004-03-23 2004-03-22 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
45.10
US$405,900 		9,000 -28.9% 45.10 US$405,900
2004-03-19 2004-03-19 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
46.30
US$416,700 		9,000 -28.9% 46.30 US$416,700
2004-03-19 2004-03-18 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
46.65
US$419,850 		9,000 -28.9% 46.65 US$419,850
2004-03-19 2004-03-17 PlS Planned sale LANCE SEAN P Non-Executive Director
4,370 -16.5%
46.94
US$205,128 		4,370 -16.5% 46.94 US$205,128
2004-03-19 2004-03-17 PlS Planned sale LANCE SEAN P Non-Executive Director
4,630 -17.3%
46.94
US$217,332 		4,630 -17.3% 46.94 US$217,332
2004-03-16 2004-03-16 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
46.86
US$421,740 		9,000 -28.9% 46.86 US$421,740
2004-03-15 2004-03-15 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
47.66
US$428,940 		9,000 -28.9% 47.66 US$428,940
2004-03-12 2004-03-12 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
47.60
US$428,400 		9,000 -28.9% 47.60 US$428,400
2004-03-11 2004-03-11 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
47.72
US$429,480 		9,000 -28.9% 47.72 US$429,480
2004-03-10 2004-03-10 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.26
US$434,340 		9,000 -28.9% 48.26 US$434,340
2004-03-09 2004-03-09 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.27
US$434,430 		9,000 -28.9% 48.27 US$434,430
2004-03-08 2004-03-08 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
49.37
US$444,330 		9,000 -28.9% 49.37 US$444,330
2004-03-05 2004-03-05 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.77
US$438,930 		9,000 -28.9% 48.77 US$438,930
2004-03-04 2004-03-04 PlS Planned sale LANCE SEAN P Non-Executive Director
6,000 -21.3%
48.53
US$291,180 		6,000 -21.3% 48.53 US$291,180
2004-03-04 2004-03-04 PlS Planned sale LANCE SEAN P Non-Executive Director
3,000 -11.9%
48.53
US$145,590 		3,000 -11.9% 48.53 US$145,590
2004-03-03 2004-03-03 PlS Planned sale LANCE SEAN P Non-Executive Director
9,000 -28.9%
48.88
US$439,920 		9,000 -28.9% 48.88 US$439,920
2004-03-02 2004-03-02 PlS Planned sale LANCE SEAN P Non-Executive Director
1,500 -6.3%
49.20
US$73,800 		1,500 -6.3% 49.20 US$73,800
2004-03-02 2004-03-02 PlS Planned sale LANCE SEAN P Non-Executive Director
3,000 -11.9%
49.22
US$147,660 		3,000 -11.9% 49.22 US$147,660
2004-03-02 2004-03-02 PlS Planned sale LANCE SEAN P Non-Executive Director
1,500 -6.3%
49.40
US$74,100 		1,500 -6.3% 49.40 US$74,100
2004-03-02 2004-03-02 PlS Planned sale LANCE SEAN P Non-Executive Director
1,500 -6.3%
49.50
US$74,250 		1,500 -6.3% 49.50 US$74,250
2004-03-02 2004-03-02 PlS Planned sale LANCE SEAN P Non-Executive Director
1,500 -6.3%
49.61
US$74,415 		1,500 -6.3% 49.61 US$74,415
2004-03-01 2004-03-01 PlS Planned sale LANCE SEAN P Non-Executive Director
3,000 -11.9%
49.38
US$148,140 		3,000 -11.9% 49.38 US$148,140
2004-03-01 2004-03-01 PlS Planned sale LANCE SEAN P Non-Executive Director
3,000 -11.9%
49.34
US$148,020 		3,000 -11.9% 49.34 US$148,020
2004-03-01 2004-03-01 PlS Planned sale LANCE SEAN P Non-Executive Director
3,000 -11.9%
49.10
US$147,300 		3,000 -11.9% 49.10 US$147,300
2004-02-27 2004-02-27 PlS Planned sale LANCE SEAN P
9,000 -28.9%
49.31
US$443,790 		9,000 -28.9% 49.31 US$443,790
2004-02-26 2004-02-26 PlS Planned sale LANCE SEAN P
9,000 -28.9%
49.18
US$442,620 		9,000 -28.9% 49.18 US$442,620
2004-02-25 2004-02-25 PlS Planned sale LANCE SEAN P
9,000 -28.9%
49.20
US$442,800 		9,000 -28.9% 49.20 US$442,800
2004-02-24 2004-02-24 PlS Planned sale LANCE SEAN P
9,000 -28.9%
49.04
US$441,360 		9,000 -28.9% 49.04 US$441,360
2004-02-23 2004-02-23 PlS Planned sale LANCE SEAN P
9,000 -28.9%
49.35
US$444,150 		9,000 -28.9% 49.35 US$444,150
2004-02-20 2004-02-20 PlS Planned sale LANCE SEAN P
9,000 -28.9%
50.30
US$452,700 		9,000 -28.9% 50.30 US$452,700
2004-02-19 2004-02-19 PlS Planned sale LANCE SEAN P
9,000 -28.9%
51.03
US$459,270 		9,000 -28.9% 51.03 US$459,270
2004-02-18 2004-02-18 PlS Planned sale LANCE SEAN P
9,000 -28.9%
50.26
US$452,340 		9,000 -28.9% 50.26 US$452,340
Explore more

More insider trading research around Novartis Vaccines and Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America